High-risk breast lesions, which comprise benign lesions and in situ carcinomas (lobular
carcinoma in situ and ductal carcinoma in situ), are clinically, morphologically, and …

Infiltrating lobular breast cancer (ILBC) is the most common special breast cancer subtype.
This review provides a comprehensive description of ILBC characteristics, including …

Needle core biopsy is considered the histological diagnostic method of choice for screen-
detected breast lesions. Although the majority are definitively diagnosed as normal, benign …

Purpose The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in
situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

Background Pleomorphic lobular carcinoma in situ (PLCIS) is an unusual variant of LCIS for
which optimal management remains unclear. Methods We conducted a 15-year (2000 …

In Western societies and other developed countries, cancer is the leading cause of death,
after cardiovascular disease. It is therefore a major component of medical undergraduate …

Purpose: Little is known about the role of the immune system in the earliest stages of breast
carcinogenesis. We studied quantitative differences in immune cell types between breast …

Benign breast disease is a spectrum of common disorders. The majority of patients with a
clinical breast lesion will have benign process. Management involves symptom control when …

Pathologists frequently encounter non‐malignant histological findings in percutaneous core
needle biopsies (CNB s). Standards for the management of patients with lesions such as …